Breakthrough in Oncology Research

We’re thrilled to share early results from our Phase II clinical trials of Oncurex, a next-generation therapy targeting aggressive forms of lung cancer.

Addressing Antimicrobial Resistance

Antimicrobial resistance (AMR) is a growing global threat. Great Odum is launching a new line of broad-spectrum antibiotics developed through AI-assisted compound screening.

Corporate Social Responsibility

Access to medicine begins with access to diagnosis. As part of our CSR initiative, we hosted over 50 free health camps across underserved regions, benefiting more than 25,000 people.

New Manufacturing Facility

To meet increasing demand and ensure uninterrupted supply, we’ve inaugurated our state-of-the-art manufacturing plant in [City/Country]. Equipped with GMP-certified technology and sustainable waste management.